Medicinova (MNOV) Current Leases (2020 - 2026)
Medicinova (MNOV) posted quarterly Current Leases of $194331.0 for Q4 2025, little changed year-over-year from $193769.0 in Q4 2024, and up 7.51% quarter-over-quarter from $180751.0 in Q3 2025.
Medicinova (MNOV) Current Leases (2020 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Current Leases for 6 consecutive years, with $194331.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases changed 0.29% year-over-year to $194331.0; the TTM figure through Dec 2025 stood at $194331.0 (changed 0.29% YoY), while the FY2025 annual figure was $194331.0, changed 0.29% from the prior year.
- Current Leases advanced to $194331.0 in Q4 2025 per MNOV's latest filing, from $180751.0 in the prior quarter.
- Across five years, Current Leases topped out at $217887.0 in Q1 2024 and bottomed at $124932.0 in Q1 2021.
- Historically, Current Leases has averaged $178840.8 across 5 years, with a median of $184842.0 in 2025.
- Annual changes were most pronounced in 2021 — Current Leases dropped 29.06% — and 2024, when it soared 53.23%.
- Medicinova's Current Leases stood at $131965.0 in 2021, then gained by 19.35% to $157505.0 in 2022, then surged by 37.09% to $215926.0 in 2023, then decreased by 10.26% to $193769.0 in 2024, then grew by 0.29% to $194331.0 in 2025.
- Business Quant data shows MNOV's Current Leases at $194331.0 in Q4 2025, $180751.0 in Q3 2025, and $184842.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | 117,038.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 117,038.00 |
| Dec 31, 2025 | 194,331.00 |
| Sep 30, 2025 | 180,751.00 |
| Jun 30, 2025 | 184,842.00 |
| Mar 31, 2025 | 189,860.00 |
| Dec 31, 2024 | 193,769.00 |
| Sep 30, 2024 | 201,976.00 |
| Jun 30, 2024 | 190,047.00 |
| Mar 31, 2024 | 217,887.00 |
| Dec 31, 2023 | 215,926.00 |
| Sep 30, 2023 | 205,394.00 |
| Jun 30, 2023 | 201,277.00 |
| Mar 31, 2023 | 142,197.00 |
| Dec 31, 2022 | 157,505.00 |
| Sep 30, 2022 | 167,073.00 |
| Jun 30, 2022 | 183,616.00 |
| Mar 31, 2022 | 163,945.00 |
| Dec 31, 2021 | 131,965.00 |
| Sep 30, 2021 | 150,682.00 |
| Mar 31, 2021 | 124,932.00 |